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Background: Tea consumption has been reported to be associated with an decreased risk of several types of
cancers. However, the results based on epidemiological studies on the association of tea consumption with bladder
cancer were inconsistent. This meta-analysis was undertaken to evaluate the relationship between tea consumption
and bladder cancer risk.
Methods: Eligible studies were retrieved via both computer searches and review of references. The summary
relative risk (RR) with 95% confidence interval (CI) was calculated.
Results: Twenty three studies met the inclusion criteria of the meta-analysis. No association with bladder cancer
was observed in either overall tea consumption group (OR =0.94, 95% CI 0.85-1.04) or subgroups stratified by sex,
study design, geographical region or tea types.
Conclusions: Our findings did not support that tea consumption was related to the decreased risk of bladder
cancer.
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In the United States, an estimated 70,530 new cases of
bladder cancer will be diagnosed and approximately
14,680 deaths were attributed to bladder cancer in 2010
[1]. Bladder cancer is the most expensive cancer to sur-
vey and treat because of the need for frequent interval
cystourethroscopy, urine cytology and radiological eva-
luations [2]. Therefore, more and more attention has
been given to chemoprevention. Cancer chemopreven-
tion is defined as the use of natural, synthetic, or bio-
logic chemical agents to reverse, suppress, or prevent
carcinogenic progression to invasive cancer. Bladder
cancer has a protracted course of progression and may
be ideal for chemoprevention strategies [3].
Tea, derived from the plant Camellia sinensis, is one
of the most common beverages consumed worldwide,
especially in China. Multiple lines of evidence support a
protective effect of tea on various cancers [4]. The em-
peror of China, ShenNung, is credited with first describ-
ing the therapeutic effects of tea in 2737 BC [5]. Studies* Correspondence: urology@yeah.net
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show that tea or the active ingredient in tea, polyphe-
nols, could afford protection against a variety of cancer
types [4]. However, the results based on epidemiological
studies on the association of tea consumption with blad-
der cancer were inconsistent. A meta-analysis conducted
in 2001 suggested the consumption of tea seems not to
be related to an increased risk of urinary tract cancer [6].
The purpose of the present study was to update and
quantitatively assess the association between tea con-
sumption and the risk of bladder cancer by summarizing
the results of published cohort and case-control studies.
We also sought to address the unresolved issue of
whether this relationship differs across the tea type.Results
In total, we identified 35 papers examining the risk of
bladder cancer with tea consumption published between
1966 and December 2011, and these were reviewed by 2
authors. We found no relevant non-English language
papers in this field. Six studies were excluded because of
insufficient information to compute its relative risk (RR)
and 95% confidence interval (CI) [7-9], or a summary. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ing [10-12]. Six studies were excluded because they were
found to be subsets of other studies or have overlapping
data and were excluded [13-18]. Thus, 23 studies [19-41]
were included in the meta-analysis on the association of
tea consumption with bladder cancer risk. There were
six cohorts [26,29,31,33,38,40] and seventeen case–
control studies; nine of these were population-based
[19-21,23,27,30,34,37,41] and eight were hospital-based
case-control studies [22,24,25,28,32,35,36,39]. Of the
twenty-three studies, seventeen were conducted in West-
ern countries [17,20-27,29,30,32-34,36,37,40,41], and six
were conducted in Asia [19,28,31,35,38,39]. Only eight
articles reported association between consumption of
specific tea types (green or black tea) and the risk of
bladder cancer [19,23,25,26,31,35,38,39]. Information on
tea consumption was obtained by interview, self-
administered questionnaire or both techniques.
Table 1 presents the basic characteristics of each study
included in our meta-analysis. Of the seventeen case-
control studies, most studies found no significant associ-
ation between tea consumption and bladder cancer,
whereas four studies reported significantly increased
risks [20,28,36,41], and three found inverse associations
[19,30,35]. Of the six cohort studies, five reported no
significant association between tea consumption and
bladder cancer [26,29,31,38,40], whereas one found sig-
nificantly decreased risk [33].
Figure 1 plots the pooled risk estimates for overall tea
consumption by study design. When all these studies
were analyzed together, no association was observed for
tea consumption with bladder cancer (OR 0.94, 95% CI
0.85, 1.04) and the summary ORs were similar across
study design and source of the controls in case-control
studies. No statistically significant heterogeneity was
observed when all the studies were analyzed together.
However, we noted some heterogeneity in the population-
based case-control studies (I2 58.2%, P=0.014). After
excluding one study by Slattery et al. [41], which reported
the highest point estimates, the P-value for heterogeneity
in the subgroup was no longer statistically significant
(I2 15.2%, P 0.311), and the summary OR was not signifi-
cantly changed (OR 0.94, 95% CI 0.83, 1.05). There was no
indication of publication bias from the Begg funnel plot
(Figure 2).
The results of subgroup analyzes by sex (men and
women), geographical region (US/Canada, Europe, Uruguay
and Asia) and tea type (green tea and black tea) are
shown in Table 2. The OR estimates from subgroup
analysis varied little, showing tea consumption was not
associated with the likelihood of bladder cancer when
separately analyzed by sex, geographical regions or tea
type. In the subgroup analysis by tea type (Figure 3), we
noted that green tea or black tea consumption was notassociated with bladder cancer risk (OR 0.97, 95% CI
0.73, 1.21; OR 0.79, 95% CI 0.59, 0.99). There was weak
heterogeneity among studies for black tea. We per-
formed a sensitivity analysis, which removed one study
at a time. This analysis confirmed the stability of the
results for black tea. No indication of publication bias
was observed from either with the Egger or Begg test in
any subgroup.
Discussion
There has been considerable interest in the possible im-
pact of tea consumption on bladder cancer risk due to
the modifiable nature of tea consumption. In this meta-
analysis of epidemiological studies of the association be-
tween tea and risk of bladder cancer including six
cohorts and seventeen case-control studies, we found
that tea consumption was not associated with reduced
risk of bladder cancer.
A previous meta-analysis by Zeegers et al. [6] found
no association between tea consumption and bladder
cancer risk. The authors reported that the consumption
of tea seems not to be related to an increased risk of
urinary tract cancer. Our finding is consistent with their
results. However, our study included 11 studies pub-
lished after 2000 that were not included in the previous
meta-analysis. We pooled the OR estimates by sex (men
and women), tea type (green tea and black tea), geo-
graphical region (US/Canada, Europe, Uruguay and
Asia), and study design (cohort or case-control studies).
Studies conducted on cell-culture systems and animal
models as well as human epidemiological studies show
that tea could afford protection against a variety of can-
cer types. Several laboratory studies have tried to investi-
gate the link between tea and bladder cancer. Most of
tea research on bladder cancer to date has focused on
the effect and mechanism of green tea. It is generally
agreed that many of the chemoprevention effects of
green tea are mediated by polyphenols. The major cate-
chins in green tea are epigallocatechin-3-gallate (EGCG),
epicatechin-3-gallate, epigallocatechin, and epicatechin.
EGCG accounts for 50% to 80% of catechin in green tea.
Our previous study indicates that EGCG induces apop-
tosis in human bladder cancer T24 cells [42]. Kember-
ling et al. found that green tea (15% of which are
polyphenols) have shown efficacy against rat bladder
cancer induced by N-(4-hydroxybutyl)-N-bytyl-nitro-
same (OH-BBN) [5]. The non-significant findings
regarding the effects of tea consumption on bladder can-
cer in our meta-analyses contradict the results of previ-
ous experimental studies on this topic using in vitro
bladder cancer cell lines and in vivo animal models. The
difference between the results from experimental studies
and our meta-analyses is likely to be due to the lower
quantities of human tea consumption compared to the














Variables of adjustment Tea drinking
assessment
Ros et al. [40] Cohort European
countries
1992-2000 513/233,236 Urinary tract Tea Age, sex, smoking status Questionnaire
Hemelt et al. [39] HCC China 2005-2008 419/384
(green tea)
Bladder Green tea Age, sex, smoking status, smoking






Kurahashi et al. [38] Cohort Japan 1990-2005 164/49,566
(men)





Jiang et al. [37] PCC US 1987-1999 1,586/1,586 Bladder Tea Age, sex, race, level of education, use
of NSAIDs, carotenoid intake,
number of years as hairdresser/
barber, cigarette smoking status,
duration of smoking, and intensity of
smoking.
Questionnaire
Stefani et al. [36] HCC Uruguay 1996-2000 255/501 Bladder Tea Age, sex, residence, urban/rural
status, education, family history of
bladder cancer among first-degree
relatives, body mass index,
occupation, smoking status, years
since quitting, number of cigarettes
smoked per day, maté drinking, soft
drink intake, milk intake, and, coffee
drinking
Both
Wakai et al. [35] HCC Japan 1994-2000 124/744 Urinary tract Green tea Age, sex, cumulative consumption of
cigarettes, year of first visit
Questionnaire
Black tea
Woolcott et al. [34] PCC Canada 1992-1994 927/2118 Bladder Tea Age, sex, education level, current
smoking, cumulative smoking, and
intake of energy, calcium, fibre and
beer
Questionnaire
Zeegers et al. [33] Cohort Netherland 1986-1992 569/3,123 Bladder Tea Age, sex, number of cigarettes/day,





HCC France 1984-1987 765/765 Bladder Tea Age, sex smoking, residence, center Interview
Bianch et al. [30] PCC USA 1986-1989 1,452/2,434 Bladder Tea Age, sex, education, smoking status,
family history of bladder cancer, high
risk occupation, total beverage
consumption, years of chlorinated
surface water, vegetable and coffee
consumption
Questionnaire
Nagano et al. [31] Cohort Japan 1979-1981 114/3,8540 Bladder Green tea Age, gender, radiation dose, smoking
status, education level, body-mass
index, and calendar time
Questionnaire
Black tea
Lu et al. [28] HCC Taiwan 1996-1997 40/160 Bladder Tea age, sex, date of admission, family
history, ethnicity, and smoking status.
Questionnaire
Michaud et al. [29] Cohort US 1986-1996 252/47,909 Bladder Tea Geographic region, age, pack-years
of smoking, current smoking status,
energy intake, intake of fruits and
vegetables, and intake of all other
beverages.
Questionnaire
Bruemmer et al. [27] PCC US 1987-1990 262/405 Bladder Tea Age, sex, smoking, county Interview
Chyou et al. [26] Cohort US 1965-1968 96/7,995 Urinary tract Green tea Age, smoking Both
Black tea
Kunze et al. [25] HCC Germany 1977-1985 675/675 Urinary tract Black tea Age, sex, smoking Interview
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Table 1 Study characteristics of published cohort and case-control studies on tea consumption and bladder cancer
(Continued)
D’Avanzo et al. [24] HCC Italy 1985-1990 555/855 Bladder Tea Age, sex, education, smoking habits,
alcohol drinking and exposure to
occupational risk
Interview
Nomura et al. [23] PCC US 1977-1986 261/522 Urinary tract Black tea Age, sex, pack-years of cigarette
smoking
Interview
Clavel et al. [22] HCC France 1984-1987 690/690 Bladder Tea Age, sex, smoking Interview
Slattery et al. [18] PCC US 1977-1982 419/889 Bladder Tea Age, sex, smoking status, diabetes
and bladder infection
Interview
Risch et al. [21] PCC Canada 1979-1982 876/1,668 Bladder Tea Age, sex, residence, and lifetime
cigarette consumption.
Interview
Jensen et al. [20] PCC Denmark 1979-1981 371/771 Bladder Tea Age, sex, smoking status, Interview
Ohno et al. [19] PCC Japan 1976-1978 293/589 Urinary tract Black tea Age, smoking Interview
PCC: population-based case-control study, HCC: hospital-based case-control study, NSAIDs: non-steroidal anti-inflammatory drugs, Both: questionnaire and
interview.
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availability is an important factor for consideration.
As a meta-analysis of previously published observa-
tional studies, our study has several limitations that need
to be taken into account when considering its contribu-
tions. First, our meta-analysis only included publishedFigure 1 A forest plot showing risk estimates from case-control and c
consumption and risk for bladder cancer..articles. Unpublished studies were not searched for our
analysis. Second, we did not include studies with insuffi-
cient information to estimate an adjusted OR, which
could bring publication bias even though no significant
evidence of publication bias was observed in the Egger
or the Begg tests. Third, our meta-analysis is likelyohort studies estimating the association between tea
Figure 2 Funnel plot of tea consumption and bladder cancer risk..
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Tea exposure is mostly assessed regarding the number
of cups of tea consumed daily or weekly. However, cup
size may vary considerably. Fourth, only eight studies
performed analyses and reported the RR separately for
black tea and green tea. All other studies referred simply
to tea. Finally, studies included in our meta-analysis
were mainly conducted in Europe, US, Canada, Uruguay,
and Asia; therefore, we are not able to generalize our
findings for all populations. Also, most studies just
included bladder cancer without specifying the type.
Transitional cell carcinoma is the most common type of
cancer in these regions and we found no relevant papersTable 2 Summary of pooled odds ratios (ORs)for bladder













All studies 23 0.94 (0.85, 1.04) 0.103 (28.3%) 0.518 0.267
Sex
Men 10 1.03 (0.91, 1.14) 0.534 (0.0%) 0.446 0.348
Women 9 0.85 (0.69, 1.01) 0.461 (0.0%) 0.638 0.348
Geographical region
Asia 6 0.85 (0.69, 1.00) 0.784 (0.0%) 0.360 0.348
Europe 7 0.92 (0.77, 1.08) 0.841 (0.0%) 0.789 0.881
Uruguay 1 4.10 (0.00, 8.20) - - -
US/Canada 9 1.02 (0.83, 1.21) 0.008 (61.2%) 0.723 0.835
Tea type
Green tea 5 0.97 (0.73, 1.21) 0.793 (0.0%) 0.377 0.221
Black tea 7 0.79 (0.59, 0.79) 0.176 (33.1%) 0.381 0.764on squamous cell carcinoma. So the results are mainly
based on transitional cell carcinoma but not squamous
cell carcinoma.
Conclusions
In conclusion, in this pooled analysis of six cohort and
seventeen case-control studies, we did not find that tea
consumption was associated with decreased risk of blad-
der cancer. Given the small number of cohort studies
included in this meta-analysis, further research from
large epidemiological studies is needed in this area.
Methods
Literature research
We searched and reviewed the MEDLINE database
using PubMed, Web of Science and the Cochrane Li-
brary, using selected common key words related to tea
consumption and bladder cancer risk in case-control
and cohort studies. We also scanned bibliographies of
relevant articles in order to identify additional studies.
As the key words for the literature search, we selected
tea for the exposure factors, and bladder cancer for the
outcome factors. The articles evaluating the relationship
of urinary tract cancer and tea consumption were also
retrieved, because the overwhelming majority of tumors
occurred in the bladder, and the renal pelvis and ureter
are covered by the same urothelium. The term bladder
cancer was used as a synonym for these neoplasms.
Each identified publication was reviewed and included
in the analysis if all the following criteria were met: first,
they had to be case-control or cohort studies; second,
papers reported in English between 1966 and December
2011; last, the result of each study was expressed as rela-
tive risk (RR) or odds ratio (OR) together with its
Figure 3 Forest plots showing the risk estimates from each study and the pooled risk estimates for green tea and black tea..
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adjusted for age, sex and smoking at the least, or suffi-
cient information allowing us to compute them.Data extraction
Data from all articles were retrieved independently by
JQ and QM while the methods and results sections were
removed and coded to blind the assessors to this infor-
mation. The following data were collected: the first
author’s name, the year of publication, country of origin,
the study design (cohort or case-control), number of
participants (cases and cohort size, or cases and con-
trols), anatomical site of the neoplasm, adjusted effects
estimates, exposure assessment and adjusted covariates.
Considering that bladder cancer is a rare disease, the RR
was assumed to be approximately the same as the OR,
and the OR was used as the study outcome. Adjusted
ORs were extracted directly from the original reports. If
studies reported sex-stratified age- and smoking-
adjusted ORs, we calculated the overall age-, smoking-
and sex-adjusted OR by combining these estimates using
the method of Mantel and Haenszel [43].Statistical analysis
We pooled data using the DerSimonian and Laird ran-
dom effects models [44], which considers both within-
study and between-study variation. Subgroup analyses
were performed according to sex (male or female), study
design (cohort or case-control studies), the study loca-
tion (US/Canada, Europe, Uruguay or Asia) and tea
types (green tea, black tea). We quantified the extent of
heterogeneity using the Q-test [44] and the I2 score [45],
and P < 0.05 was considered statistically significant. Pub-
lication bias was assessed using the tests of Egger [46]
and Begg [47]. All statistical analyzes were performed
using Stata Statistical Software, version 10.0.Abbreviations
RR: relative risk; CI: confidence interval; OR: odds ratio; NSAID: non-steroidal
anti-inflammatory drug; EGCG: epigallocatechin-3-gallate; OH-BBN: N-(4-
hydroxybutyl)-N-bytyl-nitrosame.
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